Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 4/20 | 0.32 |
| ▸ | DPP4 | P27487 | 4/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FAP | Q12884 | 2/20 | 0.30 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 2/20 | 0.30 |
| ▸ | MAOB | P27338 | 2/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7146333 | 0.99 | CTSD (0.32) | CTSDF2DPP4MEN1KMT2A | |
| SCHEMBL7139402 | 0.87 | PTGER4 (0.36) | F2MEN1KMT2A | |
| SCHEMBL7356317 | 0.84 | F2 (0.37) | F2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7165069 | 0.83 | F2 (0.37) | F2MEN1KMT2A | |
| SCHEMBL7148757 | 0.81 | CYP3A4 (0.32) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7144856 | 0.81 | CYP3A4 (0.32) | — | |
| SCHEMBL7249203 | 0.81 | MC3R (0.33) | F2MEN1KMT2A | |
| SCHEMBL7143011 | 0.80 | F2 (0.35) | F2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7160547 | 0.80 | MC3R (0.33) | F2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7364149 | 0.80 | F2 (0.34) | F2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1515550-A | Thrombosis resisting preparation | — | 2004-07-28 | — | — | CN | claimed |
| EP-1361212-A1 | Peptide derivatives as antithrombotic agents | AstraZeneca AB (SE) | 2003-11-12 | — | — | EP | claimed |
| CN-1147205-A | antithrombotic agent | LILLY CO ELI (US) | 1997-04-09 | — | — | CN | claimed |
| EP-0672658-A1 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1995023609-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | claimed |